Reuters logo
BRIEF-Navidea Biopharmaceuticals files for non timely 10-K
March 16, 2017 / 4:28 PM / 6 months ago

BRIEF-Navidea Biopharmaceuticals files for non timely 10-K

March 16 (Reuters) - Navidea Biopharmaceuticals Inc

* Navidea biopharmaceuticals files for non timely 10-k - sec filing

* Navidea biopharmaceuticals inc - expects to report revenues for the year ended december 31, 2016 of $22.0 million compared to $13.2 million for 2015

* Navidea biopharmaceuticals inc - expects operating expenses for year ended december 31, 2016 to be about $21.9 million versus $30.0 million for 2015 Source text : bit.ly/2mwOvzg Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below